Bertrand Loy, Director at HARVARD BIOSCIENCE INC (HBIO), bought 10,759 shares at $3.19 ($35K) on 2022-08-18, disclosed to the SEC on 2022-08-22.
Open-market purchase of $35k HBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 1,151 | $4K | 10.4% |
| 2 | $3.28 | 9,608 | $32K | 89.6% |
| Total | $3.27 avg | 10,759 | $35K | 100% |
| Filing → |
| ENTG | SELL | 2026-02-26 | $15.2M | — | Filing → |
| ENTG | SELL | 2026-02-04 | $7.8M | — | Filing → |
| ENTG | SELL | 2025-12-03 | $8.8M | — | Filing → |